Medtronic plc. ($MDT) Stock Forecast: Up 5.3% Today

What is Medtronic plc.?

Medtronic (MDT) Bullish Movement Today

Why is Medtronic plc. going up?

MDT stock is up 5.3% on Aug 20, 2025 13:50

• Medtronic is a multinational medical technology company headquartered in Ireland, known for developing and manufacturing medical devices and equipment.
• The company reported strong Q1 earnings and revenue beats, along with an increased full-year EPS outlook, despite a slight decline in stock price.
• Q1 sales, adjusted EPS, and FY26 sales guidance all surpassed estimates.
• Analysts revised their forecasts ahead of the earnings call, expecting positive results for the company.
• The stock's positive movement today reflects the impact of the encouraging earnings report and raised sales guidance, even amid a minor drop in stock price.

MDT Price Chart

MDT Technical Analysis

MDT News

MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up

Medtronic tops on Q1 earnings and revenues, raises full-year EPS outlook, but shares dip on board changes.

https://www.zacks.com/stock/news/2735030/mdt-stock-falls-despite-q1-earnings-revenue-beat-fy26-eps-view-up

What's Going On With Medtronic Stock Tuesday? - Medtronic ( NYSE:MDT )

Q1 sales hit $8.58 billion vs. $8.38 billion expected; adjusted EPS $1.26 vs. $1.23 est. FY26 sales guidance raised to $35.72 billion-$35.82 billion vs. $35.32 billion consensus. Get the exact trades and sectors to target before August's biggest earnings-driven market moves. Details here →

https://www.benzinga.com/markets/earnings/25/08/47206568/medtronic-lifts-annual-outlook-appoints-new-directors-in-post-elliott-strategic-shift

Medtronic ( MDT ) Q1 Earnings and Revenues Top Estimates

Medtronic (MDT) delivered earnings and revenue surprises of +2.44% and +2.50%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2734433/medtronic-mdt-q1-earnings-and-revenues-top-estimates

Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Medtronic ( NYSE:MDT )

Medtronic plc MDT will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19. Analysts expect the Galway, Ireland-based company to report quarterly earnings at $1.23 per share, versus $1.23 per share in the year-ago period.

https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/47185685/medtronic-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-

Medtronic ( MDT ) Stock Declines While Market Improves: Some Information for Investors

In the closing of the recent trading day, Medtronic (MDT) stood at $91.98, denoting a -1% move from the preceding trading day.

https://www.zacks.com/stock/news/2713895/medtronic-mdt-stock-declines-while-market-improves-some-information-for-investors

Trending Today

Binance Coin ($BNB) Crypto Forecast: Up 5.0% Today

Medtronic plc. Price History

04.03.2025 - MDT Stock was down 5.5%

• MDT's stock (MDT) saw a -1.09% decrease, signifying a bearish trend.
• The decline in MDT's stock price may be linked to investors taking profits following a recent uptick.
• Concerns over potential regulatory changes in the healthcare sector could be making investors cautious, resulting in the drop in MDT's stock.
• This bearish movement in MDT's stock is likely a brief correction in response to market conditions rather than an indication of the company's underlying performance.

14.00.2025 - MDT Stock was up 5.2%

• Medtronic experienced a bullish movement, potentially influenced by positive analyst coverage and forecasts for Anteris Technologies, a player in the transcatheter valve replacement market.
• Analysts' positive outlook on Anteris Technologies' DurAVR valve system, expected to gain a significant market share by 2030, likely bolstered investor confidence in the broader medical technology sector.
• The encouragement of innovative technologies in healthcare may have positively impacted Medtronic, leading to an increase in its stock price.
• The optimistic view on advancements in transcatheter valve replacement technologies could be a contributing factor to Medtronic's overall bullish stock performance.

20.07.2025 - MDT Stock was up 5.3%

• Medtronic is a multinational medical technology company headquartered in Ireland, known for developing and manufacturing medical devices and equipment.
• The company reported strong Q1 earnings and revenue beats, along with an increased full-year EPS outlook, despite a slight decline in stock price.
• Q1 sales, adjusted EPS, and FY26 sales guidance all surpassed estimates.
• Analysts revised their forecasts ahead of the earnings call, expecting positive results for the company.
• The stock's positive movement today reflects the impact of the encouraging earnings report and raised sales guidance, even amid a minor drop in stock price.

20.01.2024 - MDT Stock was up 2.7%

• Medtronic reported a 5% increase in revenue for Q3 2024, showcasing strong performance in its core business segments.
• The decision to exit unprofitable ventilator product lines and focus on high-demand areas like diabetes and cardiac rhythm management has boosted investor confidence.
• The company's adjusted earnings exceeding consensus estimates and raising full-year outlook has further contributed to the bullish market movement.
• The positive earnings and revenue surprises have likely driven investor optimism and propelled the stock price higher.

21.10.2023 - MDT Stock was up 2.0%

• Medtronic reported strong financial results for its second quarter of fiscal year 2024, with worldwide revenue increasing by 5.3% as reported and 5.0% on an organic basis.
• The company raised its full-year outlook after doubling its profit and experiencing revenue growth in Q2.
• The diabetes segment outperformed expectations, contributing to the positive financial results and prompting Medtronic to raise its outlook.
• Overall, the bullish market movement of Medtronic's stock can be attributed to the company's strong financial performance and positive outlook, particularly driven by the success of its diabetes segment.

18.08.2023 - MDT Stock was up 1.8%

• Medtronic's stock had a strong bullish movement today, possibly driven by the following factors:
• Partnership announcements: The partnership between GE HealthCare and Mayo Clinic to accelerate work on imaging and AI, as well as FluidAI Medical teaming up with Medtronic for remote monitoring, could have generated positive sentiment and excitement about potential advancements in healthcare technology.
• Growth potential: The article mentioning investors looking for growth stocks ahead of the next bull market might have attracted investors' attention to Medtronic, considering its position in the healthcare industry and potential for future growth.
• Overall market sentiment: The bullish movement in the overall market could have influenced the positive movement in Medtronic's stock, as investors may have been more optimistic and willing to invest in various sectors, including healthcare.

22.07.2023 - MDT Stock was up 2.7%

• The bullish movement in MDT stock today can be attributed to the following factors:
• 1. Strong Q1 FY24 Performance: Medtronic reported better-than-expected Q1 FY24 sales, with organic revenue growth of 6%. The company showcased broad strength across businesses and geographies, driven by improved underlying fundamentals. The positive performance in Medtronic's heart device unit sales and spine & neurosurgery product segment sales contributed to the bullish movement.
• 2. Raised Forecast: Medtronic raised its annual forecast, indicating confidence in its future performance. The increased demand for heart devices played a significant role in powering the upbeat results and supporting the bullish market movement.
• 3. Positive Market Sentiment: The overall market sentiment, with the NZD being the strongest currency and stocks showing an upward trend, may have also influenced the bullish movement in MDT stock. However, it is important to note that these factors are indirectly related to Medtronic's specific performance.
• In conclusion, Medtronic's strong Q1 performance, raised forecast, and positive market sentiment contributed to the bullish movement in MDT stock today.

11.09.2023 - MDT Stock was down 1.8%

• Today, Medtronic (MDT) experienced a strong bearish movement in the stock market. This could be attributed to the following factors:
• 1. Sustainability Report: The articles mention Medtronic's latest Sustainability Report, which highlights the company's efforts to make progress on environmental, social, and governance (ESG) issues. While sustainability initiatives are generally positive, the market may have reacted negatively to specific challenges or concerns outlined in the report.
• 2. Market Performance: The article states that Medtronic's stock sank while the overall market was gaining. This suggests that there may be specific factors affecting Medtronic's performance, such as disappointing financial results, regulatory issues, or negative market sentiment towards the healthcare sector.
• 3. Share Holdings: an article from EIN News Finance mentions that SevenBridge Financial Group LLC raised its holdings in Medtronic. While increased holdings can be seen as a positive indicator, it is possible that the market interpreted this as a sign of potential selling pressure or lack of confidence in the company's future prospects.
• 4. Overall Market Conditions: It is important to consider the broader market conditions and trends when assessing the movement of a specific stock. Factors such as economic indicators, geopolitical events, or industry-specific news can influence investor sentiment and impact the performance of individual stocks like Medtronic.

21.04.2025 - MDT Stock was down 2.5%

• The stock declined despite surpassing Q4 forecasts and revealing plans to spin off its Diabetes business.
• The market's reaction could be attributed to profit-taking following recent positive developments, leading to a temporary downward trend.
• Investors may be exercising caution concerning the potential implications of the spinoff on Medtronic's operational efficiency and future growth opportunities.
• The stock's drop might also be influenced by broader market conditions or sector-specific factors impacting investor sentiment towards healthcare companies.

17.06.2024 - MDT Stock was up 3.6%

• Forecasts suggest a promising future for the Medical Technology Platform Market, with frontrunners like Medtronic driving innovation. This optimistic projection likely influenced the bullish trend in MDT stock.
• Medtronic's outperformance in market returns reflects investors' trust in the company's capabilities and growth prospects, boosting its stock value.
• The award bestowed upon Medtronic for its commitment to disability inclusion underscores its dedication to diversity and advancement, resonating positively with investors and buoying the stock price.
• In a quest for high-yield dividend opportunities to offset inflation, Medtronic's reliability and growth potential have piqued investors' interest, further fueling the bullish momentum in the stock.

17.06.2024 - MDT Stock was up 3.9%

• Medtronic's bullish movement could be attributed to being a high-yield dividend stock beating inflation, attracting investors looking to counter the effects of rising prices.
• The focus on undervalued healthcare stocks in the market could have positively impacted Medtronic's stock as investors seek opportunities in this sector.
• The integration of AI in healthcare for better patient outcomes could also have contributed to the positive sentiment around healthcare stocks, including Medtronic.
• The search for undervalued breakout stocks in the market may have led investors to discover the potential in companies like Medtronic, driving the bullish movement.

22.04.2025 - MDT Stock was down 5.8%

• Despite delivering strong fourth-quarter fiscal 2025 results with improvements in margins, Medtronic's stock experienced a bearish movement.
• The decision to spin off its Diabetes business into a standalone company could have initially raised concerns among investors about the potential impact on overall performance.
• The beat in Q4 earnings and revenue estimates might not have been substantial enough to offset broader market sentiment or concerns about the upcoming restructuring.
• Investor optimism about Medtronic's strength in the Cardiovascular portfolio may have been overshadowed by uncertainties surrounding the strategic shift in the company's business structure.